Neutralization of SARS-CoV-2 variants by convalescent and vaccinated serum

We tested human sera from large, demographically balanced cohorts of BNT162b2 vaccine recipients (n=51) and COVID-19 patients (n=44) for neutralizing antibodies against SARS-CoV-2 variants B.1.1.7 and B.1.351. Although the effect is more pronounced in the vaccine cohort, both B.1.1.7 and B.1.351 sho...

詳細記述

保存先:
書誌詳細
出版年:medRxiv
主要な著者: Bates, Timothy A., Leier, Hans C., Lyski, Zoe L., McBride, Savannah K., Coulter, Felicity J., Weinstein, Jules B., Goodman, James R., Lu, Zhengchun, Siegel, Sarah A. R., Sullivan, Peter, Strnad, Matt, Brunton, Amanda E., Lee, David X., Curlin, Marcel E., Messer, William B., Tafesse, Fikadu G.
フォーマット: Artigo
言語:Inglês
出版事項: Cold Spring Harbor Laboratory 2021
主題:
Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC8043482/
https://ncbi.nlm.nih.gov/pubmed/33851185
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1101/2021.04.04.21254881
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料